All change in Germany? Medtech industry watches closely
This article was originally published in Clinica
The start of autumn 2013 signals the beginning of the final campaigning for votes by Germany’s MPs, ahead of the national elections on 22 September. CDU chancellor Angela Merkel is aiming for a third successive term as head of Europe’s most powerful economy, without – or most likely with – another coalition partner. Peer Steinbrück is the man that the opposition SPD has put up to derail her plans.
You may also be interested in...
Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
The IVDR implementation schedule is problematic. European notified bodies say solutions must be grasped if public health is not to suffer.